SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K/A - Current report: [Amend]
SEC Accession No. 0001193125-22-272601
Filing Date
2022-10-28
Accepted
2022-10-28 17:00:58
Documents
13
Period of Report
2022-10-25
Items
Item 5.07: Submission of Matters to a Vote of Security Holders

Document Format Files

Seq Description Document Type Size
1 8-K/A d377859d8ka.htm   iXBRL 8-K/A 54903
  Complete submission text file 0001193125-22-272601.txt   235598

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA ignyu-20221025.xsd EX-101.SCH 4603
3 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE ignyu-20221025_def.xml EX-101.DEF 15282
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE ignyu-20221025_lab.xml EX-101.LAB 25998
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE ignyu-20221025_pre.xml EX-101.PRE 16440
7 EXTRACTED XBRL INSTANCE DOCUMENT d377859d8ka_htm.xml XML 8178
Mailing Address 277 PARK AVENUE, 26TH FLOOR NEW YORK NY 10172
Business Address 277 PARK AVENUE, 26TH FLOOR NEW YORK NY 10172 (212) 818-8800
Ignyte Acquisition Corp. (Filer) CIK: 0001834645 (see all company filings)

IRS No.: 852448157 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K/A | Act: 34 | File No.: 001-39951 | Film No.: 221342769
SIC: 2836 Biological Products, (No Diagnostic Substances)